Background. There are limited data on the performance of the pneumonia severity index (PSI) and CURB-65 (confusion, urea, respiratory rate, blood pressure, age ≥65) score, which were originally developed for communityacquired pneumonia (CAP), for patients with healthcare-associated pneumonia (HCAP).
studies comparing these scoring systems have given conflicting results, with some suggesting the PSI may be superior [5] , while others have noted no advantage to the PSI over CURB-65 [6] [7] [8] .
Traditionally, pneumonia has been classified as either community-acquired or nosocomial, depending on where the disease developed. The distinction is considered relevant because the risk factors for, microbiology of, and outcomes associated with the 2 syndromes are distinct. Recently, the term "healthcare-associated pneumonia" (HCAP) was introduced by the American Thoracic Society/Infectious Diseases Society of America guidelines [9] . HCAP refers to pneumonia that occurs out of the hospital in patients with contact or exposure to the healthcare environment [10] .
Compared to CAP, HCAP is a distinct type of pneumonia with unique microbiological and epidemiological characteristics and outcomes [11] [12] [13] [14] [15] . The patients with HCAP are generally older and have more comorbidities. Nevertheless, PSI and CURB-65 have been used to assess the severity of illness in patients with HCAP, although there are few studies validating these scoring systems in patients hospitalized with HCAP [16] [17] [18] [19] . Therefore, we evaluated the performance of the PSI and CURB-65 scoring systems in predicting the 30-day mortality in patients with HCAP compared to those with CAP.
METHODS
This retrospective, observational study with prospectively collected data was conducted at Samsung Medical Center (a 1960-bed, university-affiliated, tertiary referral hospital in Seoul, South Korea) between January 2008 and December 2010. Some of the clinical data for patients enrolled in 2008 were included in an article published in 2010 [15] . The study was approved by the Institutional Review Board of Samsung Medical Center to review and publish information obtained from patient records. Informed consent was waived because of the retrospective nature of the study.
Study Population
Over the study period, all consecutive patients admitted to the hospital through the emergency department with pneumonia were prospectively registered for the study period. The patients with hospital-acquired pneumonia that developed after being hospitalized for >72 hours or within 10 days of leaving the hospital were not included [14] . The patients who had been transferred in from other hospitals after hospitalization for >48 hours were also excluded. In addition, immunocompromised patients, such as those with neutropenia (absolute neutrophil count <1500 cells/μL) after chemotherapy or human immunodeficiency virus (HIV) infection, and those who had undergone transplantations were excluded.
Diagnosis of CAP and HCAP
A clinical diagnosis of pneumonia required the presence of new radiographic infiltrates and at least 2 of the following clinical criteria: fever (>38°C) or hypothermia (≤35°C), new cough with or without sputum production, pleuritic chest pain, dyspnea, and altered breath sounds on auscultation [20] . The patients with pneumonia were classified into CAP and HCAP groups. HCAP was defined as a diagnosis of pneumonia in patients admitted to the hospital who met at least 1 of the following criteria: (1) a recent history of hospitalization for ≥2 days in the preceding 90 days; (2) residence in a nursing home or longterm care facility; (3) recent antibiotic therapy, intravenous chemotherapy, or wound care within the past 30 days of the current infection; and (4) attendance at a hospital or hemodialysis clinic [14] [15] [16] . CAP was defined as a diagnosis of pneumonia in patients who did not meet any of the criteria for HCAP.
Microbiologic Data
An etiological diagnosis was considered when a respiratory pathogen was isolated from a usually sterile specimen, pneumococcal antigen was detected in urine, or a predominant microorganism was isolated from adequate sputum or bronchial washing fluids with compatible Gram staining, as previously reported [15] . Methicillin-resistant Staphylococcus aureus, Pseudomonas species, Acinetobacter species, Stenotrophomonas maltophilia, and extended-spectrum β-lactamase-producing Enterobacteriaceae were considered potentially drug-resistant (PDR) pathogens [13] .
The appropriateness of antibiotic therapy was analyzed for all cases with an etiological diagnosis according to susceptibility test criteria for lower respiratory tract pathogens. Antibiotic therapy was classified as being inappropriate if the initially prescribed antibiotics were not active against the identified pathogens, based on in vitro susceptibility testing [21] .
Severity Scoring Systems
Based on patient demographics and baseline clinical data that were prospectively registered, we retrieved the 20 PSI risk factors and all individual risk factors comprising the CURB-65 severity score. The PSI and CURB-65 scores were calculated using collected data, as previously reported [3, 4] . Based on a previous report [3] , the patients were classified into the PSI risk classes I-V. Likewise, all patients were assigned to 6 risk strata based on the 5 prognostic factors of CURB-65 [4] . The patients were stratified into low-, intermediate-, and high-risk groups according to the PSI and CURB-65 scoring systems, as previously reported [3, 4] . The scoring systems were compared for their capacity to predict 30-day mortality.
Statistical Analyses
The data are presented as medians and interquartile ranges for continuous variables and as numbers ( percentages) for categorical variables. The data were compared using the Mann-Whitney U test for continuous variables and Pearson χ 2 test or Fisher exact test for categorical variables.
To determine the accuracy of each score to predict 30-day mortality, we estimated the sensitivity, specificity, positive and negative predictive values, and likelihood ratios for each possible cutoff. The Youden index, defined as (sensitivity + specificity) −1, was calculated at each cutoff. The cutoff point which showed the highest Youden index was considered the optimal cutoff value [22] . The discriminatory power of each score was assessed by calculating the area under each receiver operating characteristic (ROC) curve. The estimated area under the curve (AUC) values were compared by using the Hanley-McNeil test [23] .
All tests were 2-sided, and a P value of <.05 was considered significant. The data were analyzed using PASW Statistics 18 (SPSS Inc, Chicago, Illinois) descriptive analysis and Stata software, version 11 (Stata Corp, College Station, Texas) for ROC analysis.
RESULTS

Patient Characteristics
During the study period, 1585 consecutive patients with pneumonia were hospitalized through the emergency department. Of these patients, 347 patients with hospital-acquired pneumonia, 245 immunocompromised patients, and 55 patients transferred from other hospitals after hospitalization >48 hours were excluded. Thus, in total, 938 patients hospitalized with pneumonia were eligible for this study, consisting of 519 patients (55%) with CAP and 419 patients (45%) with HCAP. The criteria for inclusion in the HCAP group are shown in Table 1 . Previous hospitalization within 90 days (62%) was the most common criterion for HCAP.
The baseline characteristics of patients with HCAP and CAP are presented in Table 2 . Patients with HCAP were significantly more likely to be male and had more comorbidities. Septic shock at presentation and need for mechanical ventilation were higher in patients with HCAP than in those with CAP (P = .005 and P = .028, respectively). In addition, admission to the intensive care unit was more common in HCAP patients. The PSI and CURB-65 scores were higher in the patients with HCAP than in those with CAP. However, there was no significant difference in the proportion of CURB-65 scores ≥2, in contrast to those of PSI risk class ≥IV.
The median lengths of antibiotic treatment and hospital stay were significantly longer in HCAP patients than in CAP patients (P = .011 and P < .001, respectively). The 30-day mortalities were 16% in HCAP patients and 5% in CAP patients (P < .001).
Pathogen Distribution
The bacterial pathogen of the pneumonia was identified in 130 patients (31%) with HCAP and in 122 patients (24%) with CAP (P = .010). The distributions of pathogens are shown in Table 3 . Overall, Streptococcus pneumoniae was the most frequently isolated pathogen in HCAP (31%) and CAP (48%) patients. The occurrence of PDR pathogens was significantly higher in HCAP patients (32%) than in CAP patients (15%; P = .002). Inappropriate initial antibiotic treatment was significantly higher in patients with HCAP than in those with CAP (25/130, 19% vs 8/122, 7%; P = .003).
Comparison of Mortality by Severity Class
The number of patients and the 30-day mortality rate across the severity classes of PSI and CURB-65 are shown in Figure 1 . The patients with HCAP were more commonly classified into the high-risk PSI classes than those with CAP (P = .003). However, the distribution of both groups according to CURB-65 class showed no difference (P = .349). The two severity scoring systems had similar trends of increasing mortality with worsening risk class in both HCAP and CAP groups (P = .083 for PSI and P = .107 for CURB-65). However, in all risk classes of the 2 scoring systems, mortality was higher in the HCAP group compared to the CAP group.
In the CAP group, the low-risk patients identified based on PSI and CURB-65 had low aggregate 30-day mortality (0.7% and 2.7%, respectively). However, in the HCAP group, the low-risk patients identified using CURB-65 had a higher aggregate 30-day mortality of 11.7% (33/281) compared with 4.9% (6/123) for the low-risk patients identified using PSI.
Performances of Severity Scoring Systems in HCAP and CAP
The sensitivity, specificity, and positive and negative predictive values for 30-day mortality at different cutoff points for each scoring system are presented in Table 4 . At every given threshold, PSI had a higher sensitivity but a lower specificity than CURB-65 in both CAP and HCAP groups. The 2 scoring systems had high negative predictive values but low positive predictive values at all cutoff points. In both the CAP and HCAP groups, the highest Youden index was shown at cutoff points of ≥IV in the PSI class and ≥2 in the CURB-65 score, which were considered the best cutoff values for 30-day mortality.
The ROC curves for 30-day mortality for each scoring system in CAP and HCAP patients are shown in Figure 2 . The PSI had a higher discriminatory power to predict 30-day mortality than CURB-65 in both the CAP group (AUC of 0.835 and 0.759, respectively; P = .018) and the HCAP group (AUC of 0.679 and 0.599, respectively; P = .009). However, the AUCs of PSI and CURB-65 in the HCAP group were significantly lower than those in the CAP group (P < .001 for PSI and P = .003 for CURB-65).
DISCUSSION
This study evaluated the performances of PSI and CURB-65 scores in predicting 30-day mortality in patients with HCAP compared to patients with CAP. In this study, the 2 severity scoring systems had similar trends of increasing mortality with worsening risk class and similar performances for predicting 30-day mortality at different cutoff points in both the HCAP and CAP groups. However, in the HCAP group, the low-risk patients identified using CURB-65 had a higher aggregate 30-day mortality compared to the low-risk patients identified using PSI. Finally, the discriminatory powers of PSI and CURB-65 for 30-day mortality were significantly lower in patients with HCAP compared to those in patients with CAP. One of the most important and difficult evaluations in the management of patients with CAP in the emergency department is an assessment of the severity of illness [1, 2] . Although the PSI and CURB-65 scores are the most widely used predictive scoring systems, each has advantages and limitations. The PSI has been primarily developed to identify patients with a low risk of mortality who could be treated as outpatients [3] ; however, this system can potentially overestimate the severity of illness in elderly patients with comorbidities. In contrast, the CURB-65 score has been developed to easily identify the high mortality-risk patients with severe illness [4] , but it is not Other gram-positive bacteria 1 (1) 0 1.000 Gram-negative pathogens
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Enterobacter species 1 (1) 2 (2) .612 Acinetobacter species 3 (2) 1 (1 Figure 1 . The number of patients and the 30-day mortality rate by each point of the pneumonia severity index (PSI) class and the CURB-65 (confusion, urea, respiratory rate, blood pressure, age ≥65) score. Each bar graph shows the number of patients in each PSI class and CURB-65 score. Each broken line shows the 30-day mortality rate in each PSI class and CURB-65 score. Abbreviations: CAP, community-acquired pneumonia; CURB-65, confusion, urea, respiratory rate, blood pressure, age ≥65; HCAP, healthcare-associated pneumonia; PSI, pneumonia severity index.
ideal for detecting patients with multiple comorbidities [24] . Despite the strengths and weakness, these scoring systems are reasonably sensitive and specific to assess the severity of illness in patients with CAP [25] . However, in the management of patients with HCAP, there are no specific scoring systems. Although PSI and CURB-65 have been used to assess the severity of illness even in patients with HCAP, there are limited data on the performance of these scoring systems. Fang et al [16] and Man et al [18] reported that scoring systems originally designed for CAP could be applied to HCAP patients. Recently, Carrabba et al [19] also reported that these scoring systems were good at predicting mortality in nonimmunocompromised HCAP patients. However, Falcone et al [17] reported that these scoring systems were less useful in patients with HCAP, particularly in predicting a low risk of mortality. This counterintuitive result may be explained by the different end points of the scoring systems used in previous studies. The PSI and CURB-65 were originally developed for predicting 30-day mortality. However, Falcone et al [17] included septic shock, intensive care unit admission, and in-hospital mortality as the adverse events that were clinical end points in the study. Our study identified that PSI and CURB-65 had similar trends of increasing mortality with worsening risk class in nonimmunocompromised HCAP patients, consistent with a recently published study by Carrabba et al [19] . In addition, the performances for predicting 30-day mortality at different cutoff points in the HCAP group were comparable to those in the CAP group. Therefore, our data suggest that PSI and CURB-65 could be applied to assess the severity of illness in the management of patients with HCAP. However, the discriminatory powers of PSI and CURB-65 for 30-day mortality were significantly lower in patients with HCAP than those in the CAP group.
From several studies comparing the severities between HCAP and CAP [14, 26] , the PSI scores were higher in HCAP patients, but the CURB-65 scores did not differ. This finding might be associated with the demographic characteristics and comorbidities, which are important in HCAP. Previous studies have shown that HCAP patients are older and have more comorbidities [11] [12] [13] [14] and therefore have higher PSI scores [12, 14] . However, these characteristics are not included in the items for CURB-65 [4] . These data suggest that the PSI score may be better than CURB-65 in predicting the 30-day mortality of patients with HCAP [16] . This is supported by our results that the AUC of PSI (0.679) was significantly higher than that of CURB-65 (0.599) to predict 30-day mortality in the HCAP group. In addition, the low-risk patients identified based on CURB-65 had a higher aggregate 30-day mortality compared to low-risk patients identified using PSI. Carrabba et al [19] also reported that low-risk patients of PSI had the lowest aggregate 30-day mortality than the low-risk patients of the other scores including CURB-65 in HCAP patients. In addition, they suggested that PSI could be considered more useful than CURB-65 in ruling out serious HCAP [19] . If the scoring systems originally developed for CAP are used to assess the severity of illness in patients with HCAP, then PSI may be better than CURB-65 to determine the site of care of HCAP patients, especially in predicting a low-risk of mortality. There are several potential limitations to our study that should be acknowledged. First, given its retrospective nature, selection bias may have influenced the significance of our findings. Although the data were retrieved from a prospectively collected pneumonia registry, we cannot exclude the possibility of recoding errors related to baseline clinical data associated with the scoring systems. Furthermore, our study was from a single institution with a comprehensive cancer center, which had a large number of cancer patients receiving chemotherapy. Although immunosuppressed patients with neutropenia developed after chemotherapy were excluded from the HCAP group, this situation could limit the generalizability of our findings to other hospitals with smaller numbers of cancer patients with risk factors for HCAP. Second, our patients may not reflect the full prognostic spectrum of patients with HCAP because we included only patients hospitalized through the emergency department. However, large numbers of patients with HCAP who could be classified into the low-risk group by PSI or CURB-65 have been hospitalized based on clinical judgment [12] . Therefore, our results represent actual practice at a tertiary referral hospital. Figure 2 . The receiver operating characteristic (ROC) curves for 30-day mortality for the pneumonia severity index (PSI) classes and the CURB-65 (confusion, urea, respiratory rate, blood pressure, age ≥65) scores. The solid lines show the ROC curve of the PSI class. The dotted lines show the ROC curve of the CURB-65 score. In patients with community-acquired pneumonia (CAP), the area under the curve (AUC) of the PSI class (0.835; 95% confidence interval [CI], .768-.901) was greater than that of the CURB-65 score (0.759; 95% CI, .686-.832; P = .018). In patients with healthcare-associated pneumonia (HCAP), the AUC of the PSI class (0.679; 95% CI, .619-.739) was also greater than that of the CURB-65 score (0.599; 95% CI, .522-.675; P = .009). The PSI class and the CURB-65 score have higher discriminatory powers in CAP patients than HCAP patients (P < .001 and P = .003, respectively). The estimated AUC values were compared by using the Hanley-McNeil test. Abbreviations: AUC, area under the curve; CAP, community-acquired pneumonia; CI, confidence interval; CURB-65, confusion, urea, respiratory rate, blood pressure, age ≥65; HCAP, healthcare-associated pneumonia; PSI, pneumonia severity index.
In conclusion, the performances of the PSI and CURB-65 scoring systems for predicting 30-day mortality in HCAP patients were comparable to those in CAP patients. However, the discriminatory powers of PSI and CURB-65 for 30-day mortality were significantly low in patients with HCAP compared to those in patients with CAP. Therefore, future studies are needed to define more accurate scores to predict outcome of HCAP patients.
Notes
